Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

A single arm, prospective, open label, multicentre study for evaluation of efficacy and safety of IV CERA for treatment of chronic renal anaemia in dialysis patients not currently treated with ESA.

Nainan GK, Pathak VR, Dalal SS, Saxena S, Mittal D, Raju TR, Gokulnath, Isaac R, Rajapurkar MM, Rana DS, Shah BV, Ray DS, Thiagarajan CM, Jha RM, Kukreja AA, Pophale RR.

J Assoc Physicians India. 2014 Mar;62(3):232-6.

PMID:
25327065
2.

Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study.

Farag YM, Mittal BV, Keithi-Reddy SR, Acharya VN, Almeida AF, C A, Ballal HS, Gaccione P, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rajapurkar MM, Rana DS, Sreedhara R, Sinha DK, Shah BV, Sunder S, Sharma RK, Seetharam S, Raju TR, Singh AK.

BMC Nephrol. 2014 Mar 6;15:42. doi: 10.1186/1471-2369-15-42.

3.

Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis.

Rajapurkar MM, Lele SS, Malavade TS, Kansara MR, Hegde UN, Gohel KD, Gang SD, Shah SV, Mukhopadhyay BN.

Indian J Nephrol. 2013 Sep;23(5):332-7. doi: 10.4103/0971-4065.116293.

4.

Human leukocyte antigen alleles, genotypes and haplotypes frequencies in renal transplant donors and recipients from West Central India.

Patel JS, Patel MM, Koringa PG, Shah TM, Patel AK, Tripathi AK, Mathew A, Rajapurkar MM, Joshi CG.

Indian J Hum Genet. 2013 Apr;19(2):219-32. doi: 10.4103/0971-6866.116122.

5.

Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study.

Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, Almeida AF, Channakeshavamurthy A, Ballal HS, P G, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rana DS, Sreedhara R, Sinha DK, V SB, Sunder S, Sharma RK, Seetharam S, Raju TR, Rajapurkar MM.

BMC Nephrol. 2013 May 28;14:114. doi: 10.1186/1471-2369-14-114.

6.

Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast-The Iscom Study.

Lele SS, Mukhopadhyay BN, Mardikar MM, Patel TA, Vasavada AK, Banker DN, Kapasi KD, Chauhan VC, Chawla KC, Raju SR, Hiremath SS, Chinchole SS, Rajapurkar MM.

Am Heart J. 2013 May;165(5):744-51. doi: 10.1016/j.ahj.2013.02.016. Epub 2013 Mar 26.

PMID:
23622911
7.

Prognostic evaluation of catalytic iron in patients with acute coronary syndromes.

Steen DL, Cannon CP, Lele SS, Rajapurkar MM, Mukhopadhyay B, Scirica BM, Murphy SA, Morrow DA.

Clin Cardiol. 2013 Mar;36(3):139-45. doi: 10.1002/clc.22089. Epub 2013 Feb 3.

PMID:
23377899
8.

Role of multi-detector computed tomography (MDCT) in management of post percutaneous nephrolithotomy (PCNL) bleeding.

Ganpule AP, Shah DH, Ganpule SA, Sabnis RB, Rajapurkar MM, Desai MR.

F1000Res. 2013 Nov 22;2:253. doi: 10.12688/f1000research.2-253.v1. eCollection 2013.

9.

Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease.

Rajapurkar MM, Hegde U, Bhattacharya A, Alam MG, Shah SV.

Toxicol Mech Methods. 2013 Jan;23(1):5-10. doi: 10.3109/15376516.2012.730558. Epub 2012 Oct 24.

PMID:
22978744
10.

What do we know about chronic kidney disease in India: first report of the Indian CKD registry.

Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, Gang S, Gupta A, Modi G, Pahari D, Pisharody R, Prakash J, Raman A, Rana DS, Sharma RK, Sahoo RN, Sakhuja V, Tatapudi RR, Jha V.

BMC Nephrol. 2012 Mar 6;13:10. doi: 10.1186/1471-2369-13-10.

11.

Association of catalytic iron with cardiovascular disease.

Rajapurkar MM, Shah SV, Lele SS, Hegde UN, Lensing SY, Gohel K, Mukhopadhyay B, Gang S, Eigenbrodt ML.

Am J Cardiol. 2012 Feb 1;109(3):438-42. doi: 10.1016/j.amjcard.2011.09.032. Epub 2011 Nov 8.

PMID:
22071209
12.

The role of catalytic iron in acute kidney injury.

Shah SV, Rajapurkar MM, Baliga R.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2329-31. doi: 10.2215/CJN.08340811. No abstract available.

13.

The role of labile iron in kidney disease and treatment with chelation.

Shah SV, Rajapurkar MM.

Hemoglobin. 2009;33(5):378-85. doi: 10.3109/03630260903212233.

PMID:
19821781
14.

Radiation nephropathy is not mitigated by antagonists of oxidative stress.

Cohen EP, Fish BL, Irving AA, Rajapurkar MM, Shah SV, Moulder JE.

Radiat Res. 2009 Aug;172(2):260-4. doi: 10.1667/RR1739.

15.

Management of non-neoplastic renal hemorrhage by transarterial embolization.

Jain V, Ganpule A, Vyas J, Muthu V, Sabnis RB, Rajapurkar MM, Desai MR.

Urology. 2009 Sep;74(3):522-6. doi: 10.1016/j.urology.2008.11.062. Epub 2009 Jul 9.

PMID:
19589577
16.

Percutaneous endovascular management of recurrent aneurysm of transplant renal artery anastomosed to internal iliac artery.

Hegde UN, Rajapurkar MM, Gang SD, Lele SS.

Indian J Urol. 2008 Jul;24(3):411-3. doi: 10.4103/0970-1591.42629.

17.

Is carbon dioxide a safe and good alternative for diatrizoate meglumine as a contrast in digital subtraction angiography?

Hegde UN, Khanapet MS, Rajapurkar MM, Gang SD, Gohel KD, Rane G, Parikh P, Patil D, Desai T, Patil P, Kelawala N.

Indian J Nephrol. 2009 Jan;19(1):15-9. doi: 10.4103/0971-4065.50675.

18.
19.

Kidney transplantation in abnormal bladder.

Mishra SK, Muthu V, Rajapurkar MM, Desai MR.

Indian J Urol. 2007 Jul;23(3):299-304. doi: 10.4103/0970-1591.33728.

20.

Ischaemia imaging in type 2 diabetic kidney transplant candidates--is coronary angiography essential?

Gang S, Dabhi M, Rajapurkar MM.

Nephrol Dial Transplant. 2007 Aug;22(8):2334-8. Epub 2007 Jun 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk